Novo Nordisk A/S: all 1,444 studies

Page 14 of 15. Open to participants first (108), then studies with results posted, then the rest; newest registration first within each.

• Observational Study to Assess the Quality of Life and Clinical Outcomes in Subjects Using NovoMix® 30 for the Treatment of DiabetesCompletedNCT00696163
• Observational Study of Glycaemic Control in Patients Uncontrolled on Oral Antidiabetic Agents and Starting With 1 (Once) Daily Levemir® (Insulin Detemir) as the Treatment of Type 2 Diabetes MellitusCompletedNCT00687284
• Observational Study of Safety and Efficacy of Levemir® in Type 2 DiabetesCompletedNCT00687063
• Comparison of the Pharmacodynamics and Pharmacokinetics of Insulin Aspart and Human Insulin in Elderly People With Type 2 DiabetesCompletedNCT00676819Phase 4
• Observational Study on Blood Glucose Control in Patients With Diabetes Using Modern InsulinCompletedNCT00676741
• Observational Study of Type 1 and Type 2 Diabetes Patients Having Switched From Human Premixes to NovoMix®30CompletedNCT00675493
• Observational Study to Assess the Efficacy and Safety of NovoRapid™ Flexpen™CompletedNCT00675220
• Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 DiabetesCompletedNCT00671008
• Observational Study on Blood Glucose Control in Patients With Diabetes Using Modern InsulinCompletedNCT00670722
• Observational Study of Patients With Diabetes Using Levemir® FlexPen®CompletedNCT00670683
• Observational Study on Treatment Satisfaction of Levemir® Versus Protaphane® During "Real-life" Usage in GermanyCompletedNCT00665808
• Safety, Efficacy, Tolerability and Pharmacokinetics of NNC 0070-0002-0182 in Overweight or Obese Male and Female VolunteersTerminatedNCT00665665Phase 1
• Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 DiabetesCompletedNCT00665093
• Safety and Efficacy of Insulin NPH Compared to a New Insulin Formulation in Subjects With Type 2 DiabetesCompletedNCT00660374Phase 2
• Observational Study of Safety and Effectiveness of NovoMix® 30 for the Treatment of DiabetesCompletedNCT00659282
• Observational Study of Type 2 Diabetes Patients Failing on Oral Anti-diabetic Agents Initiated on Levemir® or Insulatard®CompletedNCT00658099
• Observational Study in Type 2 Diabetes Treated by an Intensive Insulin Treatment (ICT) Containing Once Daily Levemir® (Insulin Detemir)CompletedNCT00657930
• Glycaemic Control and Quality of Care in Type 2 Diabetes on NovoMix® 30 Previously Treated With Mixtard® InsulinsCompletedNCT00657319
• Observational Study of Safety and Tolerability of Levemir™ FlexPen™ (Insulin Detemir) in the Treatment of Type 1 and Type 2 Diabetes MellitusCompletedNCT00655200
• Evaluation of Levemir® for the Treatment of Type 1 and 2 DiabetesCompletedNCT00655044
• Efficacy and Safety of Biphasic Insulin Aspart 30 With Metformin in Type 2 DiabetesCompletedNCT00624364Phase 4
• Efficacy and Safety of Biphasic Insulin Aspart 30 in Combination With Metformin in Type 2 DiabetesCompletedNCT00619697Phase 4
• Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or 2 DiabetesCompletedNCT00617565Phase 3
• Combination of Recombinant Human IL-21 (rIL-21) and Sunitinib in Stage IV Renal Cell Carcinoma PatientsCompletedNCT00617253Phase 2
• Comparison of Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 50 to Biphasic Insulin Aspart 70 in Type 2 DiabetesCompletedNCT00612599Phase 3
• Safety of Insulin Detemir in Children With Type 1 DiabetesCompletedNCT00605137Phase 3
• Efficacy and Safety of Biphasic Insulin Aspart 30 in Subjects With Type 2 DiabetesCompletedNCT00605111Phase 4
• Efficacy and Safety of Insulin Detemir in Combination With Insulin Aspart and Biphasic Insulin Aspart 30 in Type 2 DiabetesCompletedNCT00605020Phase 3
• Comparison of Insulin Aspart Produced by the NN2000 Process to the Current Process in Type 1 DiabetesCompletedNCT00604656Phase 3
• Safety and Efficacy of Insulin Detemir in Combination With OAD in Type 2 DiabetesCompletedNCT00604396Phase 3
• Efficacy and the Safety of Insulin Detemir in Subjects With Insulin Requiring DiabetesCompletedNCT00604344Phase 3
• Efficacy and Safety of Insulin Detemir in Type 2 Diabetes Inadequately Controlled on OHA Therapy AloneCompletedNCT00604253Phase 3
• Effect of rIL-21 on Metastases in Lymph Nodes in Melanoma Skin CancerTerminatedNCT00601861Phase 2
• Basal Bolus of Insulin Aspart Including Insulin NPH and Biphasic Insulin Aspart in Type 2 DiabetesCompletedNCT00600626Phase 3
• Efficacy and Safety of Biphasic Insulin Aspart 30 FlexPen® in Insulin Naive Subjects With Type 2 DiabetesCompletedNCT00600366Phase 4
• Biphasic Insulin Aspart 30 in Type 2 Diabetes Failing OAD TherapyCompletedNCT00598793Phase 3
• Human Insulin NPH and Insulin Aspart in Type 1 DiabetesCompletedNCT00597233Phase 4
• Efficacy and Safety of Insulin Detemir in Type 1 DiabetesCompletedNCT00595374Phase 3
• Efficacy and Safety of Insulin Aspart in Subjects With Type 1 or Type 2 DiabetesCompletedNCT00593255Phase 4
• Efficacy and Safety of Metformin Plus Biphasic Insulin Aspart 30 in Type 2 DiabetesCompletedNCT00592969Phase 4
• Safety and Efficacy of Insulin Detemir in Combination With OADs in Type 2 DiabetesCompletedNCT00592527Phase 3
• Initiation of Insulin Aspart in Type 2 DiabetesCompletedNCT00572806Phase 4
• Comparison of Glycemic Control Achieved With 2 Different NeedlesCompletedNCT00572052Phase 4
• Efficacy and Safety of Insulin Aspart in MDI or CSII in Children Below 7 Years of Age With Type 1 DiabetesCompletedNCT00571935Phase 4
• High Dose of Activated Recombinant Human Factor VII for Treatment of Mild/Moderate Joint Bleeds in Haemophilia Patients With InhibitorsCompletedNCT00571584Phase 4
• Comparison of Two Pen Systems in Patients With Diabetes Treated With InsulinCompletedNCT00569998Phase 3
• Evaluating the Use of Two Different Needles in Subjects With DiabetesCompletedNCT00569426Phase 4
• Comparison of Human Insulin Produced by the Current Process and the NN729 Process in Type 1 DiabetesCompletedNCT00569400Phase 3
• Efficacy and Safety of Repaglinide and Metformin Combined in Type 2 DiabetesCompletedNCT00568984Phase 4
• Efficacy and Safety of Repaglinide, Glurenorm® and Glucobay® in Chinese Subjects With Type 2 DiabetesCompletedNCT00568074Phase 4
• Comparison of Human Insulin to Insulin Inhalation Solution in Children With Type 1 DiabetesCompletedNCT00567775Phase 2
• Liquid Somatropin Formulation in Children With Growth Hormone DeficiencyCompletedNCT00567385Phase 4
• Comparison of Biphasic Insulin Aspart Produced by the NN2000 Process to Current Process to in Type 2 DiabetesCompletedNCT00564668Phase 3
• Preventive Effect of Treatment With Estradiol Vaginal Tablets on Recurrent Urinary Tract Infections in Post-menopausal WomenTerminatedNCT00560924Phase 3
• Efficacy and Safety of Growth Hormone Treatment in Children Small for Gestational AgeCompletedNCT00557336Phase 3
• Efficacy Study of Recombinant Interleukin-21 in the Treatment of Ovarian CancerCompletedNCT00523380Phase 2
• Safety of Inhaled Preprandial Human Insulin in Subjects With Diabetes and AsthmaTerminatedNCT00523042Phase 3
• The Effect of Insulin Detemir on Blood Glucose Control in Taiwanese Patients With Type 2 Diabetes Failing on OADCompletedNCT00521690Phase 4
• Growth Hormone Treatment in Children Born Small for Gestational Age: Assessment of SatisfactionCompletedNCT00519844Phase 4
• Growth Hormone Deficiency in Adults (GHDA)CompletedNCT00519558Phase 3
• Comparison of Insulin Detemir Versus Insulin NPH on Weight Change in Overweight and Obese With Type 2 DiabetesCompletedNCT00504673Phase 3
• Self-control Trial to Evaluate the Remission Rate in Newly Diagnosed Type 2 Diabetes Patients After Treatment With Insulin AspartCompletedNCT00494988Phase 4
• Efficacy and Safety of Repaglinide and Metformin Combination Therapy in Type 2 Diabetes Failing on Oral Anti-diabetic DrugsCompletedNCT00491725Phase 4
• Safety and Effect of Biphasic Insulin Aspart 50 in Patients With Type 2 Diabetes Mellitus.CompletedNCT00476437Phase 3
• Safety of Inhaled Human Insulin in Subjects With Diabetes Mellitus and Chronic Obstructive Pulmonary Disease (COPD)TerminatedNCT00472953Phase 3
• Efficacy and Safety of Inhaled Insulin Compared to Metformin and Glimepiride in Type 2 DiabetesTerminatedNCT00469586Phase 3
• Efficacy and Safety of 17-Beta Estradiol in Treatment of Atrophic VaginitisCompletedNCT00465192Phase 3
• Evaluation of Safety and Efficacy of 17-Beta Estradiol in Treatment of Atrophic Vaginitis: An Extension TrialCompletedNCT00464971Phase 3
• Effect of Inhaled Pre-prandial Human Insulin on Blood Glucose Control in Type 2 DiabetesTerminatedNCT00427154Phase 3
• Recombinant Factor VIIa in Acute Intracerebral HaemorrhageCompletedNCT00426803Phase 2
• Effect of Exercise on the Absorption of Inhaled Human Insulin in Subjects With Type 1 DiabetesCompletedNCT00419718Phase 1
• Effect of Inhaled Insulin (AERx® iDMS) on Blood Glucose Control in Type 2 DiabetesTerminatedNCT00411892Phase 3
• Comparison of Antibody Levels in Children and Adolescents After Initiation of Insulin Therapy by Either Insulin Aspart or Soluble Human InsulinCompletedNCT00410033Not applicable
• A Study Looking Into the Effect of NNC 55-0414 in Subjects With Type 2 DiabetesCompletedNCT00400283Phase 1
• Effect of Repaglinide and Metformin Combination Tablet or Rosiglitazone and Metformin in Fixed Dose Combination on Blood Glucose Control in Patients With Type 2 DiabetesCompletedNCT00399711Phase 3
• Effect of Insulin Detemir on Blood Glucose Control in Subjects With Type 2 DiabetesCompletedNCT00383877Phase 3
• Efficacy and Safety of Insulin Aspart vs. Human Insulin During Pregnancy by Women With Type 1 DiabetesCompletedNCT00365170Phase 4
• Efficacy and Safety of Inhaled Pre-prandial Human Insulin in Type 2 DiabetesTerminatedNCT00348712Phase 3
• Safety and Efficacy of Inhaled Pre-prandial Human Insulin in Type 2 DiabetesTerminatedNCT00343980Phase 3
• Comparison of NovoFine® Needles (4 mm vs. 6 mm)CompletedNCT00343343Phase 2
• Efficacy Study of IL-21 to Treat Metastatic MelanomaCompletedNCT00336986Phase 2
• Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 DiabetesCompletedNCT00333151Phase 3
• Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 DiabetesCompletedNCT00331851Phase 3
• Safety and Efficacy of Inhaled Insulin in Type 2 DiabetesTerminatedNCT00331604Phase 3
• Evaluation of Recombinant Factor VIIa in Patients With Severe Bleeding Due to TraumaWithdrawnNCT00323570Phase 3
• Safety and Efficacy of Inhaled Insulin in Type 1 DiabetesTerminatedNCT00322257Phase 3
• Efficacy and Safety of Three Times a Day BIAsp-70 Compared to Two Times a Day BIAsp-30 in Subjects With Type 2 DiabetesCompletedNCT00318786Phase 3
• Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 DiabetesCompletedNCT00318422Phase 3
• The Effect of Exercise on Blood Glucose Levels in Patients With Type 1 Diabetes: A Comparison of 3 Long-acting InsulinsCompletedNCT00313742Phase 4
• Effects of Biphasic Insulin Aspart 70/30 vs. Exenatide in Type 2 Diabetes Patients Not Reaching Blood Glucose Targets on Metformin and a Sulfonylurea.CompletedNCT00313001Phase 3
• Comparison of Efficacy and Safety of Insulin Detemir and NPH Insulin in Children and Adolescents With Type 1 DiabetesCompletedNCT00312156Phase 3
• Comparison of Efficacy and Safety of Insulin Detemir and Insulin Glargine in Patients With Type 1 DiabetesCompletedNCT00312104Phase 3
• Comparison of Insulin Detemir or Insulin Glargine as Add on to Oral Antidiabetic Drugs in Type 2 DiabetesCompletedNCT00283751Phase 3
• Effect of Biphasic Insulin Compared to Biphasic Insulin Combined With Insulin Aspart, With or Without Metformin in Type 2 DiabetesCompletedNCT00282451Phase 4
• Effect of Biphasic Insulin Aspart 30 on Blood Glucose Control in Subjects With Type 2 DiabetesCompletedNCT00280046Phase 3
• Efficacy and Safety of a Fixed or a Flexible Supplementary Insulin Therapy in Type 2 DiabetesCompletedNCT00274274Phase 4
• Efficacy and Safety of Insulin Aspart Versus Glibenclamide in Type 2 DiabetesTerminatedNCT00267683Phase 3
• Factor VIIa in Acute Intracerebral HaemorrhageCompletedNCT00266006Phase 2
• Comparison of Self Adjustment Versus Standard of Care Treatment in Subjects With Type 2 DiabetesCompletedNCT00264901Phase 4
• Effect of Growth Hormone in Children With Growth Hormone DeficiencyCompletedNCT00262249Phase 3

← Novo Nordisk A/S overview and focus areas